155 related articles for article (PubMed ID: 37068478)
21. Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
[TBL] [Abstract][Full Text] [Related]
22. Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.
Yuan ZG; Dun XY; Li YH; Hou J
J Hematol Oncol; 2009 Apr; 2():19. PubMed ID: 19400935
[TBL] [Abstract][Full Text] [Related]
23. EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.
Shivane A; Pearce A; Khatib N; Smith MEF
Int J Surg Pathol; 2018 Jun; 26(4):338-341. PubMed ID: 29198143
[TBL] [Abstract][Full Text] [Related]
24. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
Karki NR; Arfa AS; Savage N; Kutlar A
Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
[TBL] [Abstract][Full Text] [Related]
25. Castleman Disease and Rosai-Dorfman Disease.
Piris MA; Aguirregoicoa E; Montes-Moreno S; Celeiro-Muñoz C
Semin Diagn Pathol; 2018 Jan; 35(1):44-53. PubMed ID: 29217303
[TBL] [Abstract][Full Text] [Related]
26. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
27. Multifocal Castleman disease in pediatrics: case report.
Baserga M; Rosin M; Schoen M; Young G
J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
[TBL] [Abstract][Full Text] [Related]
28. An unusual cause of ascites: Castleman disease.
Zhu X; Chen S; Fang F; Jia Y; Zhang K
BMC Gastroenterol; 2021 Dec; 21(1):477. PubMed ID: 34915856
[TBL] [Abstract][Full Text] [Related]
29. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
[TBL] [Abstract][Full Text] [Related]
30. Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.
Patel AS; Geller RL; Goswami ND
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):127-128. PubMed ID: 29345958
[No Abstract] [Full Text] [Related]
31. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease.
Qian S; Ding M; Hou H; Wang Z; Zhang J; Zhang Y; Dong M; Zhu L; Wang G; Li W; Zhang X
Front Immunol; 2022; 13():899073. PubMed ID: 35655778
[TBL] [Abstract][Full Text] [Related]
33. POEMS syndrome: cicatricial alopecia as an unusual cutaneous manifestation associated with an underlying plasmacytoma.
Weichenthal M; Stemm AV; Ramsauer J; Mensing H; Feller AC; Meigel W
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):808-12. PubMed ID: 10321621
[TBL] [Abstract][Full Text] [Related]
34. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
González García A; Fernández-Martín J; Robles Marhuenda Á
Rheumatology (Oxford); 2023 Apr; 62(4):1426-1435. PubMed ID: 35997567
[TBL] [Abstract][Full Text] [Related]
35. Atypical lymphoproliferative disorders: Castleman's disease. Case report and review of the literature.
Martino G; Cariati S; Tintisona O; Veneroso S; De Villa F; Vergine M; Monti M
Tumori; 2004; 90(3):352-5. PubMed ID: 15315321
[TBL] [Abstract][Full Text] [Related]
36. Systemic lupus erythematosus complicated with Castleman disease: a case-based review.
Demirkan FG; Doğan S; Kalyoncu Uçar A; Sönmez HE; Aktay Ayaz N
Rheumatol Int; 2021 Feb; 41(2):475-479. PubMed ID: 32797278
[TBL] [Abstract][Full Text] [Related]
37. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review.
Larroche C; Cacoub P; Soulier J; Oksenhendler E; Clauvel JP; Piette JC; Raphael M
Am J Hematol; 2002 Feb; 69(2):119-26. PubMed ID: 11835348
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab).
Ibrahim K; Maghfoor I; Elghazaly A; Bakshi N; Mohamed SY; Aljurf M
Hematol Oncol Stem Cell Ther; 2011; 4(2):100-2. PubMed ID: 21727772
[TBL] [Abstract][Full Text] [Related]
39. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.
Dupin N; Diss TL; Kellam P; Tulliez M; Du MQ; Sicard D; Weiss RA; Isaacson PG; Boshoff C
Blood; 2000 Feb; 95(4):1406-12. PubMed ID: 10666218
[TBL] [Abstract][Full Text] [Related]
40. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
